COVID-19 백신 포장 및 전달 기기 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 지역별, 부문별 예측(2025-2030년)

COVID-19 Vaccine Packaging And Delivery Devices Market Growth & Trends:

The global COVID-19 vaccine packaging and delivery devices market size is expected to reach USD 3.73 billion by 2030, registering a CAGR of 1.4% from 2025 to 2030, as per the new report by Grand View Research, Inc. High demand for immunization for the ongoing pandemic and manufacturer's initiatives to expand their production capacities are the factors expected to boost the demand for packaging materials.

The hurtling vaccine inoculation rate and growing public trust in COVID-19 vaccines are anticipated to fuel the growth of the market. According to the global attitude towards the COVID-19 vaccine survey, the share of people going for immunization has increased significantly in 2021. The increasing public willingness to get vaccinated early is expected to drive the manufacturing and distribution process, propelling market growth over the forecast period.

The increasing funding and investments in R&D activities specific to the development of an innovative vaccine, packaging material, and delivery devices are anticipated to fuel the growth of the market during the forecast period. For instance, the federal government of the U.S. invested USD 143 million to develop plastic alternatives to conventional glass vials for the storage of biological liquids.

Scientists around the world are investigating the scope of needles free delivery that would eliminate the need for vials and syringes hindering the market growth in the extended run. For instance, scientists at the University of Texas developed a film-based peelable inexpensive COVID-19 vaccine delivery device. On the other side, Bharath Biotech develops an innovative nasal vaccine to battle COVID-19.

COVID-19 Vaccine Packaging And Delivery Devices Market Report Highlights:

• The syringes segment led the market with the largest revenue share of 62.04% in 2024 and is anticipated to register at the fastest CAGR over the forecast period.
• Vials are typically made of plastic or glass, with glass being preferred for COVID-19 vaccine storage due to its chemical stability.
• The COVID-19 vaccine packaging and delivery devices market in North America is anticipated to grow at the fastest CAGR during the forecast period.
• Asia Pacific dominated the COVID-19 vaccine packaging and delivery devices market with the largest revenue share of 33.39% in 2024, driven by the region's large-scale vaccination campaigns.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. Regional scope
  • 1.2.3. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in North America
    • 1.4.5.2. Data for primary interviews in Europe
    • 1.4.5.3. Data for primary interviews in Asia Pacific
    • 1.4.5.4. Data for primary interviews in Latin America
    • 1.4.5.5. Data for Primary interviews in MEA
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product outlook
• 2.3. Regional outlook
• 2.4. Competitive Insights

Chapter 3. COVID-19 Vaccine Packaging And Delivery Devices Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. High demand for efficient vaccine distribution
    • 3.2.1.2. Government and international organization funding
    • 3.2.1.3. Increased focus on vaccine accessibility
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Supply chain disruptions
    • 3.2.2.2. Regulatory and compliance challenges
• 3.3. COVID-19 Vaccine Packaging And Delivery Devices Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic landscape
    • 3.3.2.3. Social landscape
    • 3.3.2.4. Technological landscape
    • 3.3.2.5. Environmental landscape
    • 3.3.2.6. Legal landscape

Chapter 4. COVID-19 Vaccine Packaging And Delivery Devices Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. COVID-19 Vaccine Packaging And Delivery Devices Market: Product Movement Analysis
• 4.3. COVID-19 Vaccine Packaging And Delivery Devices Market by Product Outlook (USD Million)
• 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 4.5. Vials
  • 4.5.1. Vials Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5.2. Glass
    • 4.5.2.1. Glass Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5.3. Plastic
    • 4.5.3.1. Plastic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.6. Syringes
  • 4.6.1. Syringes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6.2. Empty
    • 4.6.2.1. Empty Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6.3. Prefilled
    • 4.6.3.1. Prefilled Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. COVID-19 Vaccine Packaging And Delivery Devices Market: Regional Estimates & Trend Analysis

• 5.1. Regional Dashboard
• 5.2. Regional COVID-19 Vaccine Packaging And Delivery Devices Market movement analysis
• 5.3. COVID-19 Vaccine Packaging And Delivery Devices Market: Regional Estimates & Trend Analysis by Technology & Type
• 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 5.5. North America
  • 5.5.1. North America COVID-19 Vaccine Packaging And Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5.2. U.S.
    • 5.5.2.1. Key Country Dynamics
    • 5.5.2.2. Competitive Scenario
    • 5.5.2.3. Regulatory Framework
    • 5.5.2.4. Reimbursement scenario
    • 5.5.2.5. U.S. COVID-19 Vaccine Packaging And Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5.3. Canada
    • 5.5.3.1. Key Country Dynamics
    • 5.5.3.2. Competitive Scenario
    • 5.5.3.3. Regulatory Framework
    • 5.5.3.4. Reimbursement scenario
    • 5.5.3.5. Canada COVID-19 Vaccine Packaging And Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5.4. Mexico
    • 5.5.4.1. Key Country Dynamics
    • 5.5.4.2. Competitive Scenario
    • 5.5.4.3. Regulatory Framework
    • 5.5.4.4. Reimbursement scenario
    • 5.5.4.5. Mexico COVID-19 Vaccine Packaging And Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.6. Europe
  • 5.6.1. Europe COVID-19 Vaccine Packaging And Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6.2. UK
    • 5.6.2.1. Key Country Dynamics
    • 5.6.2.2. Competitive Scenario
    • 5.6.2.3. Regulatory Framework
    • 5.6.2.4. Reimbursement scenario
    • 5.6.2.5. UK COVID-19 Vaccine Packaging And Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6.3. Germany
    • 5.6.3.1. Key Country Dynamics
    • 5.6.3.2. Competitive Scenario
    • 5.6.3.3. Regulatory Framework
    • 5.6.3.4. Reimbursement scenario
    • 5.6.3.5. Germany COVID-19 Vaccine Packaging And Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6.4. France
    • 5.6.4.1. Key Country Dynamics
    • 5.6.4.2. Competitive Scenario
    • 5.6.4.3. Regulatory Framework
    • 5.6.4.4. Reimbursement scenario
    • 5.6.4.5. France COVID-19 Vaccine Packaging And Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6.5. Italy
    • 5.6.5.1. Key Country Dynamics
    • 5.6.5.2. Competitive Scenario
    • 5.6.5.3. Regulatory Framework
    • 5.6.5.4. Reimbursement scenario
    • 5.6.5.5. Italy COVID-19 Vaccine Packaging And Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6.6. Spain
    • 5.6.6.1. Key Country Dynamics
    • 5.6.6.2. Competitive Scenario
    • 5.6.6.3. Regulatory Framework
    • 5.6.6.4. Reimbursement scenario
    • 5.6.6.5. Spain COVID-19 Vaccine Packaging And Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6.7. Denmark
    • 5.6.7.1. Key Country Dynamics
    • 5.6.7.2. Competitive Scenario
    • 5.6.7.3. Regulatory Framework
    • 5.6.7.4. Reimbursement scenario
    • 5.6.7.5. Denmark COVID-19 Vaccine Packaging And Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6.8. Sweden
    • 5.6.8.1. Key Country Dynamics
    • 5.6.8.2. Competitive Scenario
    • 5.6.8.3. Regulatory Framework
    • 5.6.8.4. Reimbursement scenario
    • 5.6.8.5. Sweden COVID-19 Vaccine Packaging And Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6.9. Norway
    • 5.6.9.1. Key Country Dynamics
    • 5.6.9.2. Competitive Scenario
    • 5.6.9.3. Regulatory Framework
    • 5.6.9.4. Reimbursement scenario
    • 5.6.9.5. Norway COVID-19 Vaccine Packaging And Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.7. Asia Pacific
  • 5.7.1. Asia Pacific COVID-19 Vaccine Packaging And Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7.2. Japan
    • 5.7.2.1. Key Country Dynamics
    • 5.7.2.2. Competitive Scenario
    • 5.7.2.3. Regulatory Framework
    • 5.7.2.4. Reimbursement scenario
    • 5.7.2.5. Japan COVID-19 Vaccine Packaging And Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7.3. China
    • 5.7.3.1. Key Country Dynamics
    • 5.7.3.2. Competitive Scenario
    • 5.7.3.3. Regulatory Framework
    • 5.7.3.4. Reimbursement scenario
    • 5.7.3.5. China COVID-19 Vaccine Packaging And Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7.4. India
    • 5.7.4.1. Key Country Dynamics
    • 5.7.4.2. Competitive Scenario
    • 5.7.4.3. Regulatory Framework
    • 5.7.4.4. Reimbursement scenario
    • 5.7.4.5. India COVID-19 Vaccine Packaging And Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7.5. South Korea
    • 5.7.5.1. Key Country Dynamics
    • 5.7.5.2. Competitive Scenario
    • 5.7.5.3. Regulatory Framework
    • 5.7.5.4. Reimbursement scenario
    • 5.7.5.5. South Korea COVID-19 Vaccine Packaging And Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7.6. Australia
    • 5.7.6.1. Key Country Dynamics
    • 5.7.6.2. Competitive Scenario
    • 5.7.6.3. Regulatory Framework
    • 5.7.6.4. Reimbursement scenario
    • 5.7.6.5. Australia COVID-19 Vaccine Packaging And Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7.7. Thailand
    • 5.7.7.1. Key Country Dynamics
    • 5.7.7.2. Competitive Scenario
    • 5.7.7.3. Regulatory Framework
    • 5.7.7.4. Reimbursement scenario
    • 5.7.7.5. Thailand COVID-19 Vaccine Packaging And Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.8. Latin America
  • 5.8.1. Latin America COVID-19 Vaccine Packaging And Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.8.2. Brazil
    • 5.8.2.1. Key Country Dynamics
    • 5.8.2.2. Competitive Scenario
    • 5.8.2.3. Regulatory Framework
    • 5.8.2.4. Reimbursement scenario
    • 5.8.2.5. Brazil COVID-19 Vaccine Packaging And Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.8.3. Argentina
    • 5.8.3.1. Key Country Dynamics
    • 5.8.3.2. Competitive Scenario
    • 5.8.3.3. Regulatory Framework
    • 5.8.3.4. Reimbursement scenario
    • 5.8.3.5. Argentina COVID-19 Vaccine Packaging And Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.9. Middle East & Africa
  • 5.9.1. Middle East & Africa COVID-19 Vaccine Packaging And Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.9.2. South Africa
    • 5.9.2.1. Key Country Dynamics
    • 5.9.2.2. Competitive Scenario
    • 5.9.2.3. Regulatory Framework
    • 5.9.2.4. Reimbursement scenario
    • 5.9.2.5. South Africa COVID-19 Vaccine Packaging And Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.9.3. Saudi Arabia
    • 5.9.3.1. Key Country Dynamics
    • 5.9.3.2. Competitive Scenario
    • 5.9.3.3. Regulatory Framework
    • 5.9.3.4. Reimbursement scenario
    • 5.9.3.5. Saudi Arabia COVID-19 Vaccine Packaging And Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.9.4. UAE
    • 5.9.4.1. Key Country Dynamics
    • 5.9.4.2. Competitive Scenario
    • 5.9.4.3. Regulatory Framework
    • 5.9.4.4. Reimbursement scenario
    • 5.9.4.5. UAE COVID-19 Vaccine Packaging And Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.9.5. Kuwait
    • 5.9.5.1. Key Country Dynamics
    • 5.9.5.2. Competitive Scenario
    • 5.9.5.3. Regulatory Framework
    • 5.9.5.4. Reimbursement scenario
    • 5.9.5.5. Kuwait COVID-19 Vaccine Packaging And Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Competitive Landscape

• 6.1. Market Participant Categorization
• 6.2. Key Company Profiles
  • 6.2.1. BD
    • 6.2.1.1. Company overview
    • 6.2.1.2. Financial performance
    • 6.2.1.3. Product benchmarking
    • 6.2.1.4. Strategic initiatives
  • 6.2.2. B. Braun Melsungen AG
    • 6.2.2.1. Company overview
    • 6.2.2.2. Financial performance
    • 6.2.2.3. Product benchmarking
    • 6.2.2.4. Strategic initiatives
  • 6.2.3. Hindustan Syringes & Medical Devices Ltd.
    • 6.2.3.1. Company overview
    • 6.2.3.2. Financial performance
    • 6.2.3.3. Product benchmarking
    • 6.2.3.4. Strategic initiatives
  • 6.2.4. Terumo
    • 6.2.4.1. Company overview
    • 6.2.4.2. Financial performance
    • 6.2.4.3. Product benchmarking
    • 6.2.4.4. Strategic initiatives
  • 6.2.5. NIPRO Medical Corporation
    • 6.2.5.1. Company overview
    • 6.2.5.2. Financial performance
    • 6.2.5.3. Product benchmarking
    • 6.2.5.4. Strategic initiatives
  • 6.2.6. SCHOTT AG
    • 6.2.6.1. Company overview
    • 6.2.6.2. Financial performance
    • 6.2.6.3. Product benchmarking
    • 6.2.6.4. Strategic initiatives
  • 6.2.7. Gerresheimer AG
    • 6.2.7.1. Company overview
    • 6.2.7.2. Financial performance
    • 6.2.7.3. Product benchmarking
    • 6.2.7.4. Strategic initiatives
  • 6.2.8. Cardinal Health
    • 6.2.8.1. Company overview
    • 6.2.8.2. Financial performance
    • 6.2.8.3. Product benchmarking
    • 6.2.8.4. Strategic initiatives